Profile data is unavailable for this security.
About the company
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
- Revenue in JPY (TTM)302.08bn
- Net income in JPY27.72bn
- Incorporated1925
- Employees4.14k
- LocationSanten Pharmaceutical Co Ltd3-9-19, Shimo-Shinjo, Higashiyodogawa-kuOSAKA-SHI 530-8552JapanJPN
- Phone+81 676648621
- Fax+81 663593827
- Websitehttps://www.santen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 185.13bn | 23.47bn | 498.67bn | 7.68k | 20.73 | 2.82 | -- | 2.69 | 0.7569 | 0.7569 | 5.99 | 5.57 | 0.4889 | 1.03 | 3.47 | 1,124,103.00 | 6.14 | 5.41 | 8.37 | 7.93 | 59.50 | 60.45 | 12.56 | 10.64 | 0.8795 | 6.70 | 0.475 | 32.12 | 24.42 | 10.57 | 139.52 | 12.81 | 23.86 | 9.63 |
| Ajanta Pharma Ltd | 75.25bn | 13.72bn | 500.88bn | 7.71k | 36.64 | -- | 30.89 | 6.66 | 58.24 | 58.24 | 319.08 | -- | -- | -- | -- | 5,233,334.00 | -- | 16.13 | -- | 19.52 | 74.16 | 74.01 | 18.23 | 19.22 | -- | 100.64 | -- | 15.93 | 12.02 | 11.92 | -17.50 | 4.64 | -7.86 | -- |
| HUTCHMED (China) Ltd | 130.22bn | 15.66bn | 506.35bn | 1.99k | 32.55 | 4.46 | 29.81 | 3.89 | 0.9002 | 0.9002 | 7.64 | 6.57 | 0.7258 | 7.19 | 7.69 | 3,302,467.00 | 8.76 | -14.35 | 13.36 | -20.43 | 54.12 | 36.57 | 12.06 | -31.44 | 2.60 | -- | 0.1038 | -- | 96.52 | 31.38 | 127.93 | -- | 38.65 | -- |
| Syngene International Ltd | 66.48bn | 9.33bn | 518.49bn | 6.85k | 55.74 | -- | 30.54 | 7.80 | 12.45 | 12.45 | 88.72 | -- | -- | -- | -- | 5,208,267.00 | -- | 8.80 | -- | 11.95 | 71.36 | 70.68 | 14.03 | 17.00 | -- | 6.88 | -- | -- | 22.61 | 17.54 | 17.33 | 8.74 | 7.34 | 0.00 |
| RemeGen Co Ltd | 23.08bn | -32.42bn | 520.24bn | 3.62k | -- | 4.27 | -- | 22.54 | -3.03 | -3.03 | 2.16 | 6.88 | 0.1864 | 0.4005 | 3.46 | 321,915.10 | -26.17 | -18.66 | -31.75 | -23.75 | 76.48 | 81.94 | -140.43 | -102.88 | 1.31 | -64.00 | 0.2682 | -- | 40.16 | 148.65 | -51.30 | -- | -- | -- |
| Xiamen Amoytop Biotech Co Ltd | 47.73bn | 12.86bn | 521.96bn | 1.96k | 40.57 | 12.14 | -- | 10.94 | 1.48 | 1.48 | 5.47 | 4.93 | 1.04 | 0.8541 | 6.70 | 1,135,877.00 | 28.09 | 17.96 | 32.72 | 21.02 | 93.17 | 90.48 | 26.95 | 19.17 | 3.22 | -- | 0.0037 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| J B Chemicals and Pharmaceuticals Ltd | 63.10bn | 9.58bn | 527.90bn | 5.10k | 55.91 | -- | 44.00 | 8.37 | 32.63 | 32.63 | 214.87 | -- | -- | -- | -- | 6,643,323.00 | -- | 15.37 | -- | 18.18 | 65.83 | 60.20 | 15.19 | 15.49 | -- | 15.00 | -- | 31.73 | 29.91 | 17.36 | 6.35 | 24.26 | 83.84 | 54.75 |
| Bluestar Adisseo Co | 282.64bn | 1.12bn | 533.56bn | 2.73k | 477.12 | 1.66 | -- | 1.89 | 0.0195 | 0.0195 | 4.92 | 5.61 | 0.6153 | 4.85 | 7.20 | 4,822,147.00 | 0.2458 | 5.28 | 0.2974 | 6.94 | 20.99 | 30.31 | 0.3996 | 8.76 | 0.9725 | 1.60 | 0.1209 | 21.81 | -9.26 | 2.92 | -95.82 | -43.75 | 2.74 | -19.09 |
| Gland Pharma Ltd | 91.58bn | 12.28bn | 539.44bn | 4.59k | 43.94 | -- | 30.51 | 5.89 | 39.98 | 39.98 | 298.11 | -- | -- | -- | -- | 10,713,810.00 | -- | 15.16 | -- | 16.69 | 60.54 | 53.97 | 13.41 | 26.07 | -- | 46.26 | -- | 0.00 | -17.64 | 17.43 | -35.54 | 19.46 | 21.24 | -- |
| Santen Pharmaceutical Co Ltd | 302.08bn | 27.72bn | 547.81bn | 4.14k | 19.81 | 1.83 | 12.06 | 1.81 | 75.98 | 75.98 | 823.09 | 822.49 | 0.7125 | 2.83 | 3.37 | 72,896,720.00 | 6.53 | 3.62 | 8.11 | 4.44 | 60.57 | 60.14 | 9.16 | 5.90 | 1.94 | 12.70 | 0.1719 | 74.51 | 4.80 | 4.40 | -154.96 | -- | 19.87 | 4.24 |
| Glenmark Pharmaceuticals Ltd | 219.07bn | -22.95bn | 563.42bn | 15.56k | -- | -- | -- | 2.57 | -43.61 | -25.22 | 416.16 | -- | -- | -- | -- | 7,553,779.00 | -- | 4.65 | -- | 6.46 | 61.08 | 60.78 | -9.72 | 6.46 | -- | 1.10 | -- | 10.17 | -5.86 | 4.94 | -118.02 | -- | -10.27 | 4.56 |
| Kangmei Pharmaceutical Co Ltd | 104.49bn | 2.20bn | 567.69bn | 4.41k | 257.07 | 3.74 | -- | 5.43 | 0.0074 | 0.0074 | 0.3535 | 0.5111 | 0.331 | 1.40 | 2.44 | 1,105,470.00 | 0.7034 | -17.60 | 1.08 | -32.24 | 22.69 | -72.78 | 2.12 | -101.19 | 0.8902 | -- | 0.1512 | -- | 16.60 | -22.17 | 103.81 | -22.83 | -53.51 | -- |
Data as of Apr 25 2024. Currency figures normalised to Santen Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
28.78%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 15 Sep 2023 | 22.91m | 6.30% |
| Black Creek Investment Management, Inc.as of 31 Mar 2023 | 20.84m | 5.73% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 31 Aug 2023 | 11.34m | 3.12% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 10.58m | 2.91% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 9.11m | 2.50% |
| Massachusetts Financial Services Co.as of 29 Feb 2024 | 8.66m | 2.38% |
| Nikko Asset Management Co., Ltd.as of 31 Aug 2023 | 8.20m | 2.25% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 5.12m | 1.41% |
| Goldman Sachs Asset Management LPas of 18 Apr 2024 | 4.13m | 1.14% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 3.85m | 1.06% |
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
